PLYX
Polaryx Therapeutics
$1.89
+$0.01 (+0.53%)Oct 28, 2026
Key metrics
The numbers that frame PLYX today
- Market cap
- $94.21M
- ROIC
- 1,235.7%
- Div yield
- 0%
- Debt / equity
- 0.0
Growth
Revenue and earnings trend for PLYX
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about PLYX
Is Polaryx Therapeutics a good buy?
No. Polaryx Therapeutics has poor quality. Growth looks poor. That could put pressure on the long-term business case.
What is the market capitalization of PLYX?
Polaryx Therapeutics's market capitalization is $94.21M.
Does PLYX stock pay dividends?
Polaryx Therapeutics does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for PLYX?
Polaryx Therapeutics's Debt / Equity ratio is 0.